CRISPR-Cas9 to model retinitis pigmentosa caused by mutations in splicing factors in C. Elegans

dc.contributor
Universitat de Barcelona. Facultat de Medicina i Ciències de la Salut
dc.contributor.author
Kukhtar Kukhtar, Dmytro
dc.date.accessioned
2021-09-07T09:07:37Z
dc.date.available
2021-09-07T09:07:37Z
dc.date.issued
2021-06-18
dc.identifier.uri
http://hdl.handle.net/10803/672361
dc.description
Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d’Investigació Biomèdica de Bellvitge (IDIBELL)
en_US
dc.description.abstract
Retinitis pigmentosa (RP) is a rare, heterogenic, and hereditary disease that produces gradual loss of the visual field and can cause blindness. Mutations causing RP are still unknown in about 50% of the cases. By CRISPR-Cas9, we mimicked a few splicing-related RP mutations (s-adRP) in PRPF8/prp-8 and SRNPN200/snpr-200 that were used for drug screens, identify potential disease modifiers, investigate mechanisms of the disease, and work on a system to provide functional information for gene variants. One of the alleles generated, displaying an overt phenotype, was used in a small-scale drug screen to identify small molecules capable of alleviating the phenotype. Unexpectedly, we found an FDA-approved drug having a detrimental effect on some of the s-adRP mutant strains. Since RP onset and progression are highly variable due to environmental or genetic modifiers, C. elegans could help RP prognosis by identifying such modifiers. We performed a small-scale RNAi screen on RP mutants with no overt phenotypes and found genetic interactions with other splicing- related genes: isy-1/ISY1, mog-2/SNRPA1, and cyn-15/PPWD1. Thus, secondary mutations in these genetic interactors could act as modifiers of the course of the disease. The mechanism by which s-adRP mutations selectively cause retinal deterioration is unknown. We detected some hints of genome instability in s-adRP mutants, which might explain the degenerative nature of the disease. We are taking steps towards establishing C. elegans as an RP diagnosis model by evaluating the functional impact of potential RP mutations, or variants of uncertain significance (VUS), in worms. For that purpose, we set a panel of features associated with s-adRP mutations, including a genetic interaction with a CRISPR-edited Slow Polymerase II mutant (ama-1(cer135[R743H])), mortal germline, or aberrant splicing events at specific transcripts. We partially humanized the sequence encoding the splicing factors prp-3 in the endogenous locus to investigate if such humanization is beneficial for functional studies of VUS. Therefore, our RP research line demonstrates the value of C. elegans for investigating rare diseases and for providing valuable information in search of drugs, diagnosis, and prognosis.
en_US
dc.format.extent
223 p.
en_US
dc.format.mimetype
application/pdf
dc.language.iso
eng
en_US
dc.publisher
Universitat de Barcelona
dc.rights.license
L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by/4.0/
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
*
dc.source
TDX (Tesis Doctorals en Xarxa)
dc.subject
Malalties de la retina
en_US
dc.subject
Enfermedades de la retina
en_US
dc.subject
Retinal diseases
en_US
dc.subject
Caenorhabditis elegans
en_US
dc.subject
RNA
en_US
dc.subject
ARN
en_US
dc.subject.other
Ciències de la Salut
en_US
dc.title
CRISPR-Cas9 to model retinitis pigmentosa caused by mutations in splicing factors in C. Elegans
en_US
dc.type
info:eu-repo/semantics/doctoralThesis
dc.type
info:eu-repo/semantics/publishedVersion
dc.subject.udc
617
en_US
dc.contributor.director
Cerón Madrigal, Julián
dc.contributor.tutor
Viñals Canals, Francesc
dc.embargo.terms
cap
en_US
dc.rights.accessLevel
info:eu-repo/semantics/openAccess


Documentos

KUKHTAR_PhD_THESIS.pdf

11.74Mb PDF

Este ítem aparece en la(s) siguiente(s) colección(ones)